Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 28, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • VISCERAL METASTASIS MECHANISM PROVED ESSENTIAL FOR CRPC PATIENTS

Govt Biotech SRF Recruitment at Ministry of AYUSH, Siddha Central Research Institute

Cognizant Data Analyst Life Science Recruitment | Apply Online

VISCERAL METASTASIS MECHANISM PROVED ESSENTIAL FOR CRPC PATIENTS
  • BiotechToday
  • World

VISCERAL METASTASIS MECHANISM PROVED ESSENTIAL FOR CRPC PATIENTS

bioxone October 17, 2020October 17, 2020

Aishila Kar,Amity University Kolkata

An important poor prognostic factor of prostate cancer (PC), visceral metastasis (VM), is not commonly observed in castration sensitive progression but continuously seen after castration-resistant progression. Still, the site, timing of appearance, and incidence of VM in castration-resistant patients have not yet been fully explained.

 At Kanazawa University Hospital, demographic, surgical, pathological, and follow-up data of PC patients have been treated between January 2000 and December 2016 were retrospectively examine using their medical charts. From these figures, risk factors of visceral metastasis and survival of patients with it were explained.

21 patients (1.5%) had visceral metastasis at diagnosis out of 1364 patients. 55 experienced the emergence of a new VM during treatment course out of 179 (13.1%) castration-resistant patients. Incidence of new VM, especially non-lung, like liver and adrenal metastases, grow significantly in proportion with the number of authorised treatments. Multivariate analysis showed that T stage, M stage, age, and treatment report with androgen receptor (AR) signalling-targeted agents and/or taxanes significantly grow the risk of VM. Compared with the group with VM at diagnosis, survival after diagnosis of VM following treatment was shorter.

In spite of the fact that sequential use of new AR signalling-targeted agents and taxanes for castration-resistant prostate cancer (CRPC) is a standard treatment plan, it frequently results in the development of VM. Explaining the mechanisms of VM are key to enhance survival in patients with CRPC.

Also read: Ex-situ DNA synthesis accelerated

SOURCE- https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/125241-androgen-receptor-signaling-targeted-therapy-and-taxane-chemotherapy-induce-visceral-metastasis-in-castration-resistant-prostate-cancer.htmldoi: 10.1002/pros.24082.

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged adrenal metastasis androgen receptor cancer castration-resistance CRPC liver patients prostate cancer signalling targeted agents surgical taxanes visceral metastasis

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Cognizant Data Analyst Life Science Recruitment | Apply Online

bioxone October 17, 2020

-Shristi Sharma, Team bioXone Cognizant Data Analyst Life Science Recruitment – Apply Online. Life Sciences Trainee Junior Data Analyst position vacant for eligible candidates at Cognizant. Cognizant is hiring life sciences candidates for a Junior Data Analyst position. Interested and eligible candidates check out all of the details on the same below: Job Title: Junior […]

Related Post

  • BiotechToday
  • World

RASSF10 gene’s gastric cancer inhibiting mechanisms revealed!

BioTech Today July 7, 2021July 6, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University To grow, cells have to divide. A single cell divides into two, and then four, and so on. Finally, we turn into a body with trillions of cells. Each cell undergoes differentiation to get its specialized function. From this, it might be quite clear how essential cell […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

2dFDR for confounder adjustment

bioxone July 17, 2021July 17, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Genomic profiling technologies of a high-throughput level generate a massive number of omics data. This is because such technologies enable biological system analysis at different omics levels. Statistical analysis of omics data tests the relationship between omics aspects and a covariate of interest. Observational omics studies […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

SETD2 in histone and tubulin methylation

bioxone June 21, 2021June 21, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Microtubules are the constituents of the cytoskeleton that help maintain the shape and structure of a cell as well as mediate intracellular transportation. They essentially are polymers of tubulin units and require post-translational modifications (PTMs) to function correctly. They undergo several modifications like methylation, acetylation and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy